DarshanTalks Podcast

406 Episodes

1. Will New Tariffs Disrupt Your Next Pharma Deal?

   Published: 26/02/2025
2. Protecting Patient Data in a Changing Regulatory Landscape

   Published: 25/02/2025
3. Off-Label Promotion Changes in 2025

   Published: 24/02/2025
4. Turning Physicians into Leaders

   Published: 21/02/2025
5. Key Regulatory Agencies in Pharma M&A

   Published: 20/02/2025
6. Does E6 (R3) Blur the Line Between GCP and Privacy Laws?

   Published: 19/02/2025
7. RFK Jr. Confirmed as HHS Secretary: What It Means for Healthcare Policy

   Published: 18/02/2025
8. America’s Research Future in Jeopardy

   Published: 15/02/2025
9. Trump Administration’s NIH cuts: Will they cripple US medical research?

   Published: 14/02/2025
10. DEI Under Trump: What It Means for Clinical Trials

    Published: 13/02/2025
11. CAPA & RCA: A Must for Pharma M&A

    Published: 12/02/2025
12. Trump Targets Indirect Costs in NIH Funding

    Published: 11/02/2025
13. The USAID Halt and Its Consequences for Clinical Research

    Published: 10/02/2025
14. Ebola Vaccine Trial in Record Time!

    Published: 8/02/2025
15. Your Clinical Trial Site M&A Agreement is Exposing You to Risk

    Published: 7/02/2025
16. What Does ICH E6 R3 Say About Returning Data to Participants?

    Published: 5/02/2025
17. Navigating the Ongoing HHS Communication Freeze

    Published: 4/02/2025
18. Ordinary People Are Changing Medicine

    Published: 3/02/2025
19. Trump’s First 10 Days: The Impact on Clinical Trials

    Published: 31/01/2025
20. Selling a Business with Issues

    Published: 31/01/2025